Hot Features
프리미엄
Calidi Biotherapeutics Inc (CLDI)
AMEX
무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.
SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...
SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...
SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...
SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...
Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma.Presented data supporting RTNova (CLD-400), the company’s...
- RTNova, an innovative systemic antitumor enveloped virotherapy, unlocks new possibilities in cancer therapy - RTNova addresses challenges posed by untargetable and untreatable metastatic...
SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...
SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...
Trial will evaluate multiple doses of CLD-101 for the treatment of newly diagnosed high-grade glioma CLD-101 is Calidi’s novel allogeneic immunotherapy utilizing neural stem cells to deliver...
Launched Nova Cell subsidiary with $2 million investment from Dr. Ronald Rigor to advance Calidi’s Adult Adipose Allogeneic (AAA) stem cell innovative programs Strengthened team with the...
| 기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.32 | 1.53 | 1.29 | 969128 | 1.43317935 | CS |
| 4 | -0.8 | -37.7358490566 | 2.12 | 2.2 | 1.27 | 1035199 | 1.75559643 | CS |
| 12 | 0.27 | 25.7142857143 | 1.05 | 3.89 | 0.73 | 1725906 | 2.11235083 | CS |
| 26 | -0.63 | -32.3076923077 | 1.95 | 3.89 | 0.73 | 978619 | 2.01399812 | CS |
| 52 | -13.78 | -91.2582781457 | 15.1 | 16.8 | 0.73 | 977752 | 2.70832585 | CS |
| 156 | -43.78 | -97.0731707317 | 45.1 | 50 | 0.73 | 766029 | 3.15914518 | CS |
| 260 | -43.78 | -97.0731707317 | 45.1 | 50 | 0.73 | 766029 | 3.15914518 | CS |
Monksdream
1 주 전
glenn1919
1 월 전
glenn1919
1 월 전
tw0122
2 월 전
glenn1919
2 월 전
glenn1919
2 월 전
glenn1919
2 월 전
tw0122
2 월 전
totffe
2 월 전
totffe
2 월 전
ErnieBilco
2 월 전
Monksdream
2 월 전
totffe
2 월 전
Monksdream
3 월 전
Monksdream
4 월 전
Monksdream
4 월 전
TrendTrade2016
5 월 전
Monksdream
5 월 전
Monksdream
5 월 전
ErnieBilco
6 월 전
JTORENCE
6 월 전
Invest-in-America
7 월 전
Termite7
7 월 전
accipiterr
7 월 전
accipiterr
8 월 전
ErnieBilco
8 월 전
Legend431
9 월 전
Triple nickle
9 월 전
2020trader
9 월 전
glenn1919
10 월 전
